Login to Your Account



Capricor trial yields positive data in DMD-linked heart disease

By Michael Fitzhugh
Staff Writer

Tuesday, April 25, 2017

Patients with DMD and advanced heart disease enrolled in an exploratory study of Capricor Therapeutics Inc.'s candidate, CAP-1002, saw, at the study's six-month midpoint, improved measures of cardiac structure and upper limb function.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription